glp-1 eligibility Intake Form What to say when requesting
Description
These findings suggest that GLP-1 receptor agonists may be particularly effective for individuals like Maria, whose AUD is accompanied by obesity or type 2 diabetes
Protocol: Request comprehensive blood work (thyroid panel, fasting insulin, cortisol, sex hormones, metabolic panel)
Dagogo-Jack S, Funnell MM, Davidson J
The NEJM authors reported the most common side effects as mild-to-moderate gastrointestinal events, with the trial discontinued due to adverse events in 4.4% to 7.8% of participants receiving orforglipron compared to 1.4% given the placebo
I mean, its exactly Thats exactly true
& Yu, S
